HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/4/R1391    most recent 00734.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Degen, L. Articles by Beglinger, C. Search for Related Content PubMed PubMed Citation Articles by Degen, L. Articles by Beglinger, C.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men

¹Division of Gastroenterology and Clinical Research Centre and Departments of ²Research and ³Clinical Pharmacology, University Hospital Basel, Basel, Switzerland; and ⁴Rotta Pharma Spa, Monza, Italy

Submitted 18 October 2006 ; accepted in final form 23 November 2006

Cholecystokinin (CCK), peptide YY (PYY), and ghrelin have been proposed to act as satiety hormones. CCK and PYY are stimulated during meal intake by the presence of nutrients in the small intestine, especially fat, whereas ghrelin is inhibited by eating. The sequence of events (fat intake followed by fat hydrolysis and CCK release) suggests that this process is crucial for triggering the effects. The aim of this study was therefore to investigate whether CCK mediated the effect of intraduodenal (ID) fat on ghrelin secretion and PYY release via CCK-1 receptors. Thirty-six male volunteers were studied in three consecutive, randomized, double-blind, cross-over studies: 1) 12 subjects received an ID fat infusion with or without 120 mg orlistat, an irreversible inhibitor of gastrointestinal lipases, compared with vehicle; 2) 12 subjects received ID long-chain fatty acids (LCF), ID medium-chain fatty acids (MCF), or ID vehicle; and 3) 12 subjects received ID LCF with and without the CCK-1 receptor antagonist dexloxiglumide (Dexlox) or ID vehicle plus intravenous saline (placebo). ID infusions were given for 180 min. The effects of these treatments on ghrelin concentrations and PYY release were quantified. Plasma hormone concentrations were measured in regular intervals by specific RIA systems. We found the following results. 1) ID fat induced a significant inhibition in ghrelin levels (P < 0.01) and a significant increase in PYY concentrations (P < 0.004). Inhibition of fat hydrolysis by orlistat abolished both effects. 2) LCF significantly inhibited ghrelin levels (P < 0.02) and stimulated PYY release (P < 0.008), whereas MCF were ineffective compared with controls. 3) Dexlox administration abolished the effect of LCF on ghrelin and on PYY. ID fat or LCF significantly stimulated plasma CCK (P < 0.006 and P < 0.004) compared with saline. MCF did not stimulate plasma CCK release. In summary, fat hydrolysis is essential to induce effects on ghrelin and PYY through the generation of LCF, whereas MCF are ineffective. Furthermore, LCF stimulated plasma CCK release, suggesting that peripheral CCK is the mediator of these actions. The CCK-1 receptor antagonist Dexlox abolished the effect of ID LCF, on both ghrelin and PYY. Generation of LCF through hydrolysis of fat is a critical step for fat-induced inhibition of ghrelin and stimulation of PYY in humans; the signal is mediated via CCK release and CCK-1 receptors.

peptide YY; cholecystokinin

This article has been cited by other articles:

				F. Y. Enc, T. Ones, H. L. Akin, F. Dede, H. T. Turoglu, G. Ulfer, N. Bekiroglu, G. Haklar, J. F. Rehfeld, J. J. Holst, et al. Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G482 - G489. [Abstract] [Full Text] [PDF]

				K. R. Juvonen, A.-K. Purhonen, M. Salmenkallio-Marttila, L. Lahteenmaki, D. E. Laaksonen, K.-H. Herzig, M. I. J. Uusitupa, K. S. Poutanen, and L. J. Karhunen Viscosity of Oat Bran-Enriched Beverages Influences Gastrointestinal Hormonal Responses in Healthy Humans J. Nutr., March 1, 2009; 139(3): 461 - 466. [Abstract] [Full Text] [PDF]

				I. M. Brennan, T. J. Little, K. L. Feltrin, A. J. P. M. Smout, J. M. Wishart, M. Horowitz, and C. Feinle-Bisset Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1487 - E1494. [Abstract] [Full Text] [PDF]

				B. J. Bradford, K. J. Harvatine, and M. S. Allen Dietary Unsaturated Fatty Acids Increase Plasma Glucagon-Like Peptide-1 and Cholecystokinin and May Decrease Premeal Ghrelin in Lactating Dairy Cows J Dairy Sci, April 1, 2008; 91(4): 1443 - 1450. [Abstract] [Full Text] [PDF]

				T. J. Little, K. L. Feltrin, M. Horowitz, J. H. Meyer, J. Wishart, I. M. Chapman, and C. Feinle-Bisset A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R45 - R51. [Abstract] [Full Text] [PDF]

				S. Hao, C. Sternini, and H. E. Raybould Role of CCK1 and Y2 receptors in activation of hindbrain neurons induced by intragastric administration of bitter taste receptor ligands Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R33 - R38. [Abstract] [Full Text] [PDF]